Khramova Daria S, Popov Sergey V, Golovchenko Viktoria V, Vityazev Feodor V, Paderin Nikita M, Ovodov Yury S
Institute of Physiology, Komi Science Centre, The Urals Branch of the Russian Academy of Sciences, Syktyvkar, Republic of Komi, Russia.
Nutrition. 2009 Feb;25(2):226-32. doi: 10.1016/j.nut.2008.08.004. Epub 2008 Oct 23.
We studied the effects of dietary pectins (citrus pectin [CP] and apple pectin) on oral tolerance in mice.
Pectins (1 mg/d) were administered orally for 2 wk. Tolerance was induced with 20 mg of ovalbumin (OVA). Levels of serum antibodies (immunoglobulin [Ig] G, IgG1, IgG2a, IgE) and delayed type hypersensitivity response determined in footpad tests were measured after subcutaneous injection of OVA with complete Freund's adjuvant. Concentrations of immunoreactive OVA in blood were measured by enzyme-linked immunosorbent assay after feeding the animals 20 mg of OVA. Adhesion and cytokine production (tumor necrosis factor-alpha, interferon-gamma) were measured in peritoneal macrophages.
Oral administration of CP was found to prevent the induction of immune hyporesponsiveness induced by OVA feeding. Animals fed OVA and CP were found to produce similar titers of antigen-specific serum IgG and levels of delayed type hypersensitivity response as those animals not fed OVA. CP increased levels of serum IgG1 and IgE. CP was found to enhance the penetration of immunogenic OVA into the serum. CP (1 mg/d) administered orally for 1 wk was also observed to enhance the adhesion and production of cytokines (tumor necrosis factor-alpha, interferon-gamma) in peritoneal macrophages.
CP administered orally was shown to inhibit oral tolerance. Enhancement of protein antigen penetration to the blood and activation of macrophages were found to precede the inhibitory effect and appeared to mediate it.
我们研究了膳食果胶(柑橘果胶[CP]和苹果果胶)对小鼠口服耐受的影响。
果胶(1毫克/天)口服给药2周。用20毫克卵清蛋白(OVA)诱导耐受。在皮下注射含完全弗氏佐剂的OVA后,测定足垫试验中血清抗体(免疫球蛋白[Ig]G、IgG1、IgG2a、IgE)水平和迟发型超敏反应。给动物喂食20毫克OVA后,通过酶联免疫吸附测定法测量血液中免疫反应性OVA的浓度。检测腹腔巨噬细胞的黏附及细胞因子产生情况(肿瘤坏死因子-α、干扰素-γ)。
发现口服CP可阻止OVA喂食诱导的免疫低反应性的产生。发现喂食OVA和CP的动物产生的抗原特异性血清IgG滴度和迟发型超敏反应水平与未喂食OVA的动物相似。CP增加了血清IgG1和IgE水平。发现CP可增强免疫原性OVA进入血清的穿透能力。还观察到口服1周的CP(1毫克/天)可增强腹腔巨噬细胞的黏附及细胞因子(肿瘤坏死因子-α、干扰素-γ)的产生。
口服CP可抑制口服耐受。发现蛋白质抗原向血液中的穿透增强和巨噬细胞的激活先于抑制作用并似乎介导了该作用。